ILF2 and metastatic melanoma: Consistently, the tumour tissues from stage III and IV metastatic melanoma patients had significantly increased ILF2 protein average levels (1.56 and 1.62 fold‐change, respectively) compared to the primary melanoma tissues (Figure 1E).